A clinical study to observe the effect of Mustadi Yapan Basti followed by Mustadi Ghrit Nasya in ahe related macular degeneration (dry type)

An open randomised clinical control study to evaluate the effect of Mustadi Yapan Basti followed by Mustadi Ghrit Nasya in Age Related Macular Degeneration (Dry type).

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/084902

Enrollment

Registered

2025-04-16

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H353- Degeneration of macula and posterior pole

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients showing sign and symptoms of ARMD like impaired central vision and presence of distorted vision,Scotoma. Patients showing presence of Drusens.

Exclusion criteria

Exclusion criteria: Infectious opthalmic conditions such as conjunctivitis,stye, Blepharitis,iritis etc Uncontrolled DM Uncontrolled HTN Patients with cataract or lens changes. Glaucoma Severe diseases like Optic atrophy, Optic Neuropathy,BRVO,CSR,Blindness etc HIV,HBsAg positive patients Bleeding disorders Patients with other systemic diseases like TB,epilepsy etc. Patients with mental illness Patients with autoimmune disorders like RA,HLAB27,SLE etc. Patients on drugs like HCQ,antitubercular drugs etc.

Design outcomes

Primary

Measure	Time frame
Reduction in signs and symptoms of age related macular degeneration and further disease progressionTimepoint: 96 days	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr Siddhi Avinash Bhise

R A podar medical ayu college worli Mumbai

saraladudhat63@gmail.com9869021885

Outcome results